A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease

NCT03936660 · Completed

Last updated 2026-05-28

This clinical trial tests whether a 12-month program helps adults with type 2 diabetes and a history of heart disease take all three recommended types of heart-protective medications.

Status Completed The study has finished.

Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).

Type Interventional (clinical trial)

Design Randomized, open-label (no blinding) health-services study

Participants 1,049 people

Who can join Ages 18+ · all sexes

Timeline Started 2019-07 · est. completion 2022-12

Where 44 sites · United States

What this study is testing ClinicalTrials.gov NCT03936660 ↗

Description as written by the study sponsor.

COORDINATE-Diabetes is a cluster-randomized clinical trial to test the effectiveness of an innovative, clinic-level educational intervention to improve the management of patients with type 2 diabetes mellitus and cardiovascular disease.

Treatments tested

Intense Education Intervention also known as Intervention Other

Clinics provided with existing clinical care guidelines as well as a multifaceted educational intervention to support development of an integrated, multi-disciplinary care pathway for patients with T2DM and CVD.

Main thing measured	Number of Participants Prescribed All 3 Groups of Recommended Evidence-based Medications
Sponsor	Duke University
Conditions studied	Diabetes Mellitus, Type 2, Cardiovascular Diseases
GLP-1 drugs	—

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT03936660 ↗